⌘K
Loading ticker…
As of 2026-08-24, Fennec Pharmaceuticals Inc. Common Stock (FENC) has a 3-month relative strength percentile of 74 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 6.2%, relative volume 1.13×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
FENC is in a stage 2 uptrend, week 3. Currently in a 9-day base; basing ADR 6.1% (broad 5.9%). VCP detected: no. RS line below base-start high. Distance from 50d / 200d: 8.1% / 34.9%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
FENC is held by 11 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $1M notional. Top 3 carry $2M.
Held by 18 ETFs · $13M across latest filings · largest weight 0.06% (OMFS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.01% |
| $14K |
| — |
| URTY | 0.00% | $11K | — |
| UWM | 0.00% | $11K | — |
| MSSM | 0.00% | $6K | — |
| HDG | 0.00% | $268 | — |
Showing 10 of 11 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | FENC Jan avg: -1.32% median: 0.71% win: 50% σ: 6.87% n: 4 2022-04-12 → 2026-07-31 | FENC Feb avg: 1.14% median: 1.40% win: 50% σ: 10.46% n: 4 2022-04-12 → 2026-07-31 | FENC Mar avg: -7.74% median: -10.40% win: 25% σ: 18.77% n: 4 2022-04-12 → 2026-07-31 | FENC Apr avg: -3.58% median: -1.56% win: 20% σ: 8.47% n: 5 2022-04-12 → 2026-07-31 | FENC May avg: 10.54% median: -1.13% win: 40% σ: 32.32% n: 5 2022-04-12 → 2026-07-31 | FENC Jun avg: 2.96% median: 2.22% win: 60% σ: 10.05% n: 5 2022-04-12 → 2026-07-31 | FENC Jul avg: 2.82% median: 0.91% win: 60% σ: 11.26% n: 5 2022-04-12 → 2026-07-31 | FENC Aug avg: -2.28% median: -1.81% win: 50% σ: 10.61% n: 4 2022-04-12 → 2026-07-31 (current) | FENC Sep avg: 0.76% median: -1.22% win: 50% σ: 12.16% n: 4 2022-04-12 → 2026-07-31 | FENC Oct avg: -6.24% median: -10.39% win: 25% σ: 10.12% n: 4 2022-04-12 → 2026-07-31 | FENC Nov avg: 18.69% median: 17.95% win: 75% σ: 16.99% n: 4 2022-04-12 → 2026-07-31 | FENC Dec avg: 6.78% median: 1.33% win: 50% σ: 16.34% n: 4 2022-04-12 → 2026-07-31 |